Cytoprotective regulation of the mitochondrial permeability transition pore is impaired in type 2 diabetic Goto-Kakizaki rat hearts

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 6, 2012, Pages 870-879

  Itoh, Takahito ^a   Kouzu, Hidemichi ^a   Miki, Takayuki ^a   Tanno, Masaya ^a   Kuno, Atsushi ^a   Sato, Tatsuya ^a   Sunaga, Daisuke ^a   Murase, Hiromichi ^a   Miura, Tetsuji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes mellitus; Endoplasmic reticulum stress; Infarct size; Mitochondrial permeability transition pore

Indexed keywords

4 PHENYLBUTYRIC ACID; CALCINEURIN; CHAPERONIN 60; CYCLOPHILIN D; ERYTHROPOIETIN; HEAT SHOCK PROTEIN 70; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATE TRANSPORTER; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM RETENTION CAPACITY; CELL PROTECTION; CELLULAR PARAMETERS; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GOTO KAKIZAKI RAT; HEART INFARCTION; HEART INFARCTION SIZE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; REPERFUSION INJURY; UNFOLDED PROTEIN RESPONSE;

ANIMALS; CALCINEURIN; CALCIUM; CARDIOTONIC AGENTS; CYCLOPHILINS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

RATTUS; RATTUS NORVEGICUS;

EID: 84869087639     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.10.001     Document Type: Article

References (32)

1. From A.M., Leibson C.L., Bursi F., Redfield M.M., Weston S.A., Jacobsen S.J., Rodeheffer R.J., Roger V.L. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 2006, 119:591-599.
2. Bell D.S. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 2003, 26:2433-2441.
3. Miki T., Yuda S., Kouzu H., Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev Mar 28 2012, [Epub ahead of print]. 10.1007/s10741-012-9313-3.
4. Marso S.P., Miller T., Rutherford B.D., Gibbons R.J., Qureshi M., Kalynych A., Turco M., Schultheiss H.P., Mehran R., Krucoff M.W., Lansky A.J., Stone G.W. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). Am J Cardiol 2007, 100:206-210.
5. Algeria J.R., Miller T.D., Gibbons R.J., Yi Q.L., Yusuf S. Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy. Am Heart J 2007, 154:743-750. Collaborative Organization of RheothRx Evaluation (CORE) Trial Investigators.
6. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Nishioka K., et al. Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol 2001, 38:1007-1011.
7. Miki T., Miura T., Hotta H., Tanno M., Yano T., Sato T., Terashima Y., Takada A., Ishikawa S., Shimamoto K. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phosphor-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition. Diabetes 2009, 58:2863-2872.
8. Hotta H., Miura T., Miki T., Togashi N., Maeda T., Kim S.J., Tanno M., Yano T., Kuno A., Itoh T., Satoh T., Terashima Y., Ishikawa S., Shimamoto K. Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts. Circ Res 2010, 106:129-132.
9. Tsuura Y., Ishida H., Okamoto Y., Kato S., Sakamoto K., Horie M., Ikeda H., Okada Y., Seino Y. Glucose sensitivity of ATP-sensitive K+ channels is impaired in beta-cells of the GK rat. A new genetic model of NIDDM. Diabetes 1993, 42:1446-1453.
10. Halestrap A.P. A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem Soc Trans 2010, 38:841-860.
11. Miura T., Tanno M. The mPTP and its regulatory proteins: final common targets of signal pathways for protection against necrosis. Cardiovasc Res 2012, 94:181-189.
12. Loo T.W., Clarke D.M. Chemical and pharmacological chaperones as new therapeutic agents. Expert Rev Mol Med 2007 Jun 28, 9(16):1-18.
13. Iannitti T., Palmieri B. Clinical and experimental applications of sodium phenylbutyrate. Drugs R&D 2011 Sep 1, 11(3):227-249.
14. Ikeda Y., Miura T., Sakamoto J., Miki T., Tanno M., Kobayashi H., Ohori K., Takahashi A., Shimamoto K. Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by delta-opioid receptor activation. Basic Res Cardiol 2006, 101:418-426.
15. Miki T., Miura T., Tanno M., Nishihara M., Naitoh K., Sato T., Takahashi A., Shimamoto K. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway. Basic Res Cardiol 2007, 102:163-170.
16. Das A., Salloum F.N., Xi L., Rao Y.J., Kukreja R.C. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol 2009, 296:H1236-H1243.
17. Nishihara M., Miura T., Miki T., Tanno M., Yano T., Naitoh K., Ohori K., Hotta H., Terashima Y., Shimamoto K. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cardiol 2007, 43:564-570.
18. Yano T., Miki T., Tanno M., Kuno A., Itoh T., Takada A., Sato T., Kouzu H., Shimamoto K., Miura T. Hypertensive hypertrophied myocardium is vulnerable to infarction and refractory to erythropoietin-induced protection. Hypertension 2011, 57:110-115.
19. Nishihara M., Miura T., Miki T., Sakamoto J., Tanno M., Kobayashi H., Ikeda Y., Ohori K., Takahashi A., Shimamoto K. Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Am J Physiol Heart Circ Physiol 2006, 291:H748-H755.
20. Gross E.R., Hsu A.K., Gross G.J. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta during reperfusion in intact rat hearts. Circ Res 2004, 94:960-966.
21. Miura T., Miki T. GSK-3β, a therapeutic target for cardiomyocyte protection. Circ J 2009, 73:1184-1192.
22. Terashima Y., Sato T., Yano T., Maas O., Itoh T., Miki T., Tanno M., Kuno A., Shimamoto K., Miura T. Roles of phospho-GSK-3β in myocardial protection afforded by activation of the mitochondrial K ATP channel. J Mol Cell Cardiol 2010, 49:762-770.
23. Jope R.S., Yuskaitis C.J., Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res 2007, 32:577-595.
24. Leung A.W., Varanyuwatana P., Halestrap A.P. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J Biol Chem 2008, 283:26312-26323.
25. Kirchhoff S.R., Gupta S., Knowlton A.A. Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation 2002, 105:2899-2904.
26. Ghosh J.C., Siegelin M.D., Dohi T., Altieri D.C. Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells. Cancer Res 2010, 70:8988-8993.
27. Kontos M.C., Shipley J.B., Kukreja R.C. Heat stress improves functional recovery and induces synthesis of 27- and 70-kDa heat shock proteins without preserving sarcoplasmic reticulum function in the ischemic rat heart. J Mol Cell Cardiol 1996, 28:1885-1894.
28. Yamashita N., Hoshida S., Nishida M., Igarashi J., Aoki K., Hori M., Kuzuya T., Tada M. Time course of tolerance to ischemia-reperfusion injury and induction of heat shock protein 72 by heat stress in the rat heart. J Mol Cell Cardiol 1997, 29:1815-1821.
29. Trost S.U., Omens J.H., Karlon W.J., Meyer M., Mestril R., Covell J.W., Dillmann W.H. Protection against myocardial dysfunction after a brief ischemic period in transgenic mice expressing inducible heat shock protein 70. J Clin Invest 1998, 101:855-862.
30. Okubo S., Wildner O., Shah M.R., Chelliah J.C., Hess M.L., Kukreja R.C. Gene transfer of heat-shock protein 70 reduces infarct size in vivo after ischemia/reperfusion in the rabbit heart. Circulation 2001, 103:877-881. [13].
31. Xiang F., Huang Y.S., Shi X.H., Zhang Q. Mitochondrial chaperone tumour necrosis factor receptor-associated protein 1 protects cardiomyocytes from hypoxic injury by regulating mitochondrial permeability transition pore opening. FEBS J 2010, 277:1929-1938.
32. Qu M., Zhou Z., Chen C., Li M., Pei L., Yang J., et al. Inhibition of mitochondrial permeability transition pore opening is involved in the protective effects of mortalin overexpression against beta-amyloid-induced apoptosis in SH-SY5Y cells. Neurosci Res 2012, 72:94-102.